Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.
about
Surgical resection versus liver transplant for patients with hepatocellular carcinomaLiver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinomaLiver Transplantation for Hepatocellular Carcinoma: Need for a New Patient Selection Strategy: ReplyContribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinomaNew advances in hepatocellular carcinomaLiver transplantation for hepatocellular carcinoma beyond the Milan criteria: A reviewPrediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationHepatocellular Carcinoma and Liver Transplantation: State of the ArtMultimodal treatment of hepatocellular carcinoma on cirrhosis: an updateManagement of "very early" hepatocellular carcinoma on cirrhotic patientsSurgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative techniqueLiver transplantation for advanced hepatocellular carcinomaAsian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis.Thermal ablation of hepatocellular carcinoma.DNA methylation: potential biomarker in Hepatocellular Carcinoma.Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.Value of radiofrequency ablation in the treatment of hepatocellular carcinomaInflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantationStaging of biliary tract and primary liver tumors.Complete response for advanced liver cancer during sorafenib therapy: case report.Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patientsImpact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation.Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.Resection prior to liver transplantation for hepatocellular carcinoma.A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantationTotal and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection.Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy.Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma.Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection.Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma.Prognostic prediction and treatment strategy in hepatocellular carcinoma.Updates in the management of hepatocellular carcinomaEvaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma[Operative therapy of hepatocellular carcinoma].Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.
P2860
Q24201773-9B109C7A-5394-43D0-826E-9E2F6C2D6E1DQ24540058-278FFA61-6863-4FEE-B1A2-02CD13B380F6Q24540174-70685B91-39B4-4846-9E98-7629DED0A062Q26740332-5FA430A1-AD3C-4DB4-A96D-616C7F9FDC51Q26749329-1752FD97-5D4B-4765-AD39-04FF27D2800CQ26750463-6C97FC4D-5895-45E8-858C-E8E4304A3C33Q26772329-B5557F62-42EB-46FA-AD1B-18BF48C067DAQ26781798-28A594EE-D421-4D00-84F1-8045F2839C95Q26825172-615FA257-4E61-4F8B-9EE3-BCE18FE45960Q26864406-E902D745-F10B-4C3F-A66F-EB9A214CDD90Q27690723-F3405C81-2A76-4D9F-B539-A463DD6430F6Q28074653-ABFC4D45-0C6B-467F-A149-D592CD48DD66Q30479629-EF1BBDF8-796F-4BDC-AD4D-9530553E0B5CQ31076650-6E00150B-532A-4CE3-929F-28E69057CEB1Q33323261-78057CD6-61C4-4B1F-92AA-79EAFED19BAAQ33617129-A7391576-0ED3-4982-9627-59DB64CF1416Q33622809-B784997C-60A0-48A8-BCB5-B4837F368CBFQ33661046-C2FD7EB6-5AD0-49D0-8527-37C3AD676A3AQ33718321-9DA23165-B3AB-4BA5-BFAC-A97895EA121BQ33773415-93A3BC08-F3BE-4DA8-B4B9-1CB925A92948Q33795187-8EA2D502-CDF2-45D6-B1B3-1E84FAFF0AB5Q33866389-7A55C834-724B-4E62-9BDC-E949B474C4D1Q33866483-B805412E-AE1B-4165-9071-E57F54ED4B29Q33905617-C5A0A0BF-5D28-4F8A-B630-DF9B714D7D59Q33913779-ABF64C5F-8494-4175-9611-9EA93E6D96A6Q33974096-8A6EADE6-3FFA-4B24-891E-5D2AEFC22B28Q34038193-B820C841-D3D3-42AF-9CA5-B03B4DB78278Q34081435-9B1C44F1-6F01-48E3-BFCD-F5B2739F3972Q34098070-CFFA4C16-E813-42BA-946D-C8AD7A7B97AFQ34197835-8A5FD10E-558F-4C55-8775-0E01218D49A3Q34201437-FF68560E-6B41-43A9-AFB5-F3A8BF4F4230Q34359096-7C84262E-82AC-4B06-87FD-088D11646443Q34547411-78013044-CF43-4388-B12B-5DE671FBE463Q34547469-EA6CE8FB-0654-479A-90C4-21FDE4D1AE94Q34571160-37C821CB-33A8-449D-88E3-335B64E795FDQ34647652-899F5EC9-DA28-4985-A47A-0FBD53D56282Q34663403-6095FDBF-518F-4CE9-84C9-7F9620EB0376Q34719112-48E6364E-B5E9-40CE-BA5B-03EDA7A06495Q34796473-59EB75DF-3F11-474F-B8A0-477E1AFD33A5Q34826535-264C5046-D25C-4A2C-A37E-74E5061232A2
P2860
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Vascular invasion and histopat ...... llular carcinoma in cirrhosis.
@ast
Vascular invasion and histopat ...... llular carcinoma in cirrhosis.
@en
Vascular invasion and histopat ...... llular carcinoma in cirrhosis.
@nl
type
label
Vascular invasion and histopat ...... llular carcinoma in cirrhosis.
@ast
Vascular invasion and histopat ...... llular carcinoma in cirrhosis.
@en
Vascular invasion and histopat ...... llular carcinoma in cirrhosis.
@nl
prefLabel
Vascular invasion and histopat ...... llular carcinoma in cirrhosis.
@ast
Vascular invasion and histopat ...... llular carcinoma in cirrhosis.
@en
Vascular invasion and histopat ...... llular carcinoma in cirrhosis.
@nl
P2093
P356
P1433
P1476
Vascular invasion and histopat ...... llular carcinoma in cirrhosis.
@en
P2093
Bechstein WO
Herrmann M
Settmacher U
Steinmüller T
P304
P356
10.1053/JHEP.2001.23561
P407
P577
2001-05-01T00:00:00Z